Eculizumab Rescue Therapy in Patients With Recurrent Atypical Hemolytic Uremic Syndrome After Kidney Transplantation
Authors:
- Caroline DuineveldCDCaroline Duineveld
- A.D. van ZuijlenAZA.D. van Zuijlen
- Dr.SP. BergerDBDr.SP. Berger
- J. van de WeteringJWJ. van de Wetering
Open Access
- 19 January 2023
- journal article
- research article
- Published by Elsevier in Kidney International Reports
- Vol. 8 (4) , 715-726
Abstract
No abstract availableKeywords
Funding Information
- ZonMw (836031008)
This publication has 32 references indexed in Scilit:
- Adult Post–Kidney Transplant Familial Atypical Hemolytic Uremic Syndrome Successfully Treated With Eculizumab: A Case Report and Literature ReviewAmerican Journal of Therapeutics, 2016
- A ‘silent’, new polymorphism of factor H and apparent de novo atypical haemolytic uraemic syndrome after kidney transplantationBMJ Case Reports, 2014
- Successful Long-Term Treatment of TMA with Eculizumab in a Transplanted Patient with Atypical Hemolytic Uremic Syndrome Due to MCP MutationTransplantation, 2013
- Complement Genes Strongly Predict Recurrence and Graft Outcome in Adult Renal Transplant Recipients with Atypical Hemolytic and Uremic SyndromeAmerican Journal of Transplantation, 2013
- Clinical Grand Rounds: Atypical Hemolytic Uremic SyndromeAmerican Journal of Nephrology, 2012
- Eculizumab induces long-term remission in recurrent post-transplant HUS associated with C3 gene mutationPediatric Nephrology, 2010
- Efficacy of Eculizumab in the Treatment of Recurrent Atypical Hemolytic-Uremic Syndrome After Renal TransplantationTransplantation, 2010
- Eculizumab for Atypical Hemolytic–Uremic SyndromeNew England Journal of Medicine, 2009
- Complement Mutation-Associated De Novo Thrombotic Microangiopathy Following Kidney TransplantationAmerican Journal of Transplantation, 2008
- Atypical relapse of hemolytic uremic syndrome after transplantationPediatric Nephrology, 2004